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S St tu ud dy y D De es si ig gn n:: Senescence-related markers were assessed in surgically obtained human nucleus pulposus (NP) specimens. 
P Pu ur rp po os se e:: To demonstrate the mechanism and signaling pathway involved in the senescence of NP chondrocytes. 
O Ov ve er rv vi ie ew w o of f L Li it te er ra at tu ur re e:: The population of senescent disc cells has been shown to be increased in degenerated or herniated
discs. However, the mechanism and signaling pathway involved in the senescence of NP chondrocytes are unknown. 
M Me et th ho od ds s:: We examined cell senescence markers [senescence-associated β -galactosidase (SA-β -gal), telomere length, telom-
erase activity, p53, p21, pRB and p16] and the hydrogen peroxide (H2O2) content in human NP specimens. 
R Re es su ul lt ts s:: The percentage of SA-β -gal-positive NP chondrocytes increased with age, while the telomere length and telom-
erase activity declined. However, there was no significant correlation between age and H2O2 content. The NP specimens
with grade III or IV degeneration showed significantly higher percentages of SA-β -gal-positive NP chondrocytes than
those with grade II degeneration. Immunohistochemistry showed that senescent NP chondrocytes in all specimens expressed
p53, p21, and pRB, while a few NP chondrocytes in only two specimens expressed p16. 
C Co on nc cl lu us si io on ns s:: The present study demonstrates that, with increasing age and advancing disc degeneration, senescent NP
chondrocytes increase or accumulate in the NP. Furthermore, the telomere-based p53, p21, pRB pathway, rather than the
stress-based p16, pRB pathway, plays a more important role in the senescence of NP chondrocytes in in vivo conditions. Our
results suggest that prevention or reversal of senescence of NP chondrocytes can be a novel mechanism by which to pre-
vent human disc degeneration. 
K Ke ey y W Wo or rd ds s:: Senescence, Nucleus pulposus, Chondrocytes, Intervertebral disc, Disc degeneration
Introduction
Cellular senescence is a program activated by normal
cells in response to various types of stress
1. One important
mechanism responsible for cellular senescence is progres-
sive telomere shortening and eventual telomere dysfunction
that occur due to incomplete DNA replication (an end-repli-
cation problem) at the telomeres (‘replicative senescence’
or ‘intrinsic senescence)
2-6. This end-replication problem
can be resolved by a holoenzyme telomerase, which elon-
gates the telomeric DNA in the 5’-to-3’ direction
6-11. In the
absence of telomerase, or when its expression is very low,
the telomeric DNA progressively shortens with each round
of cell division
12. In addition to replicative senescence, cel-
lular senescence can also be induced in a rapid manner by a
number of stresses that are independent of telomere shorten-
ing [‘stress-induced premature senescence’ (SIPS) or ‘stress
or aberrant signaling-induced senescence’ (STASIS)]
13,14.
Such stresses include oxidative stress, DNA damage, onco-genic activity, and other metabolic perturbations
15. 
Cellular senescence like apoptosis can be viewed as a
powerful tumor-suppressor mechanism that withdraws
cells with irreparable DNA damages from the cell cycle
16,17.
Therefore, the senescence signals, that is, a telomere-based
one or a stress-based one, trigger a DNA damage response,
and this response shares a common signaling pathway that
converges on either or both of the well-established two
tumor suppressor proteins, p53 (the p53, p21, pRB path-
way) and pRB (the p16, -pRB pathway)
1,14,15,18-20. In the p53,
p21, pRB pathway, senescence stimuli activate p53, which
can then induce senescence by activating pRB through p21,
a transcriptional target of p53. This senescence can be
reversed upon subsequent inactivation of p53. In the p16-
pRB pathway, senescence stimuli induce p16, which acti-
vates pRB. Once the pRB pathway is engaged by p16, the
senescence cannot be reversed by subsequent inactivation
of p53, silencing of p16, or inactivation of pRB
18. Although
there appears to be overlap between the two pathways, the
emerging consensus is that the p53, p21, pRB pathway
mediates the senescence that is primarily due to telomere
shortening, and the p16, pRB pathway is thought to medi-
ate premature senescence
1,14,20. However, a population of
growing cells suffers from a combination of physiologic
stresses that act simultaneously, and the relative impor-
tance of the p53, p21, pRB or p16, pRB pathway for the
senescence response may differ depending on the tissue
and the species of origin
1,20. Once cells have entered senes-
cence, they are arrested in the G1 phase of the cell cycle,
and they display a characteristic morphology (vacuolated,
flattened cells) and gene expression, including that for
markers such as a senescence-associated β -galactosidase
(SA-β -gal)
21,22. 
Degenerative changes in the intervertebral disc (IVD)
occur as a natural part of aging
23. Gruber et al and Roberts
et al recently provided important insights regarding the
close link between cellular senescence and disc degenera-
tion, based on the observation that SA-β -gal-positive disc
cells increased with advancing disc degeneration and
increased in herniated discs
24,25. However, the mechanism
and signaling pathways involved in the senescence of
nucleus pulposus (NP) chondrocytes are unknown. Our
present in vivo study demonstrated that, with increasing
age and advancing disc degeneration, senescent NP chon-
drocytes increase or accumulate in the NP. The NP chon-
drocytes in aging discs exhibited characteristic senescent
features, such as increased SA-β -gal expression, shortened
telomeres, and decreased telomerase activity. We further
show that the telomere-based p53, p21, pRB pathway,
rather than the stress-based p16-pRB pathway, plays a
more important role in the senescence of NP chondrocytes
in in vivo conditions. 
Materials and Methods
Twenty-five patients (14 female patients and 11 male
patients) who underwent open discectomy for symptomatic
herniated NP were included in this study. After thorough
removal of the protruded or extruded NP fragments, the NP
specimens remaining in the central part of the IVD were
pooled, and then they were immediately preserved at -75℃.
The NP specimens were grouped according to a grading
system for IVD degeneration that was based on the preoper-
ative magnetic resonance images (MRI)
26: there were 3
patients with grade II degeneration, 17 patients with grade
III degeneration, and 5 patients with grade IV degeneration.
In practice, no NP specimens with grade I or grade V
degeneration were available because there was no case of
NP herniation in any individual with grade I degeneration
(normal disc), and there were no remnant NP specimens in
patients with grade V degeneration (total collapse of the
disc space). The mean patient age was 49 years (range and
standard deviation [SD]: 20~75, ±14 years). 
1. Senescence-associated β -galactosidase staining
The SA-β -gal activity in the NP chondrocytes was deter-
mined using a SA-β -gal staining kit (Cell Signaling Tech-
nology). Sections (4 μ m thickness) of the frozen NP speci-
mens were placed on slides and fixed with 2% formalde-
hyde and 0.2% glutaraldehyde in phosphate buffered saline
(PBS) for 10 minutes at room temperature. The slides were
rinsed with PBS and then incubated overnight at 37℃ with
fresh SA-β -gal staining solution containing 40 mM citric
acid/sodium phosphate (pH 6.0), 150 mM NaCl, 2 mM
MgCl2, 5 mM potassium ferrocyanide, 5 mM potassium fer-
ricyanide, and 1 mg/ml of 5-bromo-4-chloro-3-indolyl-β -D-
galactopyranoside (X-gal). After being rinsed with distilled
water, the slides were counter-stained with Nuclear Fast
Red. All NP chondrocytes and SA-β -gal-positive NP chon-
drocytes on the whole section were counted (×200), and
the percentage of SA-β -gal-positive NP chondrocytes was
calculated. 
2/ ASJ: Vol. 2, No. 1, 20082. Telomere length assay
Genomic DNA was extracted from 40 mg of the NP spec-
imens using the Genomic DNA purification kit (Gentra,
Minneapolis, MN, USA). Genomic DNA (2~3 μ g) was
digested with the restriction enzymes Rsa I and Hinf I at 37
℃ for 16 hours and then electrophoresed on 0.6% agarose
gels at 50 V for 4 hours. After electrophoresis, the gel was
depurinated in 0.25 M HCl for 30 minutes and denatured in
0.4 M NaOH and 1.5 M NaCl for 30 minutes. The DNA
was then transferred by capillary transfer onto a positively
charged nylon membrane (Hybond-N, Roche; Germany).
The membrane was prehybridized in hybridization buffer
(TeloTAGGG Telomere Length Assay; Roche, Germany)
for 1 hour at 42℃ and then hybridized with a telomere
probe in hybridization buffer for 3 hours at 42℃. The mem-
brane was washed twice with washing solution and rinsed
with the recommended blocking reagent. The hybridized
probe was detected by the chemiluminescence method,
according to the manufacturer’s recommendation. The
membrane was exposed to Hyperfilm (Amersham Pharma-
cia Biotech, England). The mean telomere length was calcu-
lated using the formula: L=∑ (ODi) / ∑ (ODi/Li), where
ODi is the integrated signal intensity and Li is the DNA
length at position i.
3. Telomerase activity
The telomerase activity was analyzed with a TeloTAGGG
Telomerase PCR ELISA plus kit (Roche, Germany), accord-
ing to the manufacturer’s instructions. The frozen NP speci-
mens were suspended in 200 μ l of ice-cooled lysis reagent
and incubated in ice for 30 minutes. The lysate was cen-
trifuged at 16,000×g for 20 minutes at 4℃. The super-
natant was carefully removed and transferred into a tube for
the TRAP assay. Ten μ g of protein extract was used for
each assay. Each supernatant was divided into two aliquots.
One aliquot was inactivated at 85℃ for 10 minutes and
used as a negative control, while the other was used to eval-
uate the telomerase activity. For each test sample and con-
trol, 25 μ l of the reaction mixture and 5 μ l of the internal
standard (IS) were transferred into a tube suitable for PCR
amplification. The extended products were amplified by
PCR using Taq polymerase, the P1-TS, P2 primers, and
nucleotides. After a 30 minute incubation at 25℃ to allow
the telomerase-mediated extension of the TS primer, and 5
minutes at 94℃ to inactivate the telomerase, the reaction
mixture was subjected to 30 PCR cycles at 94℃ for 30 sec-
onds, 50℃ for 30 seconds, and 72℃ for 90 seconds, then
72℃ for 10 minutes on a thermocycler. Using the ELISA
method, the amplified products were immobilized on strep-
tavidin-coated microtiter plates via biotin-streptavidin inter-
action. The amplicons were then detected by anti-digoxi-
genin antibodies conjugated to peroxidase. After addition of
the peroxidase substrate (3, 3’, 5, 5’-tetramethyl benzidine),
the amount of TRAP products was determined by measure-
ment of absorbance at 450 nm.
4. Measurement of H2O2 content in the NP tissue
The NP tissues (20 mg) were homogenized in PBS. The
homogenate was centrifuged at 15,000 rpm for 15 minutes
at 4℃, and the supernatant was collected and stored at -75℃.
The H2O2 content was measured using the Quantitative
Hydrogen Peroxide Assay Kit (OXIS International, Foster
city, CA, USA). This assay is based on the oxidation of fer-
rous ions (Fe
2+) to ferric ions (Fe
3+) by H2O2 under acidic
conditions. The ferric ion binds with the indicator dye
xylenol orange to form a stable colored complex that can be
measured at 560 nm.
5. Immunohistochemistry
To test the immunohistochemical expression of p53, p21,
pRB, and p16
INK4 (Phamingen, San Diego, CA, USA), the
fresh-frozen specimens stored at -75℃ were embedded in
OCT (Tissue-Tek, Sakura Finetek, Torrance, CA, USA).
The embedded specimens were cut at -25℃, mounted on
lysine-coated glass slides, and then fixed for 10 minutes at 4
℃ in 4% paraformaldehyde. The endogenous peroxidase
was subsequently blocked by 3% H2O2 for 20 minutes and
0.1% Triton X-100 in PBS for 15 minutes. The cryostat sec-
tions were incubated in a humid chamber at 4℃ overnight
with the primary antibodies for p16, pRB, p21, and p53.
The sections were then exposed to a streptavidin-biotin-per-
oxidase complex (Histostain Plus kit; Zymed, San Francis-
co, CA, USA), and the color was developed with 3,3-
diaminobenzidine tetrahydrochloride (Lab Vision, Fremont,
CA, USA). Mayer’s hematoxylin was used for counterstain-
ing. 
6. Statistical analysis 
The normality of variables (age, percentages of SA-β -gal-
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activity, and H2O2 content) was assessed using the Kol-
mogorov-Smirnov test. Depending on the normality, corre-
lations among the variables were analyzed using Spear-
man’s or Pearson’s test. The differences in the means of the
variables among the degeneration grades were analyzed
using the Mann-Whitney U test.
Results
1. Senescence-associated β -galactosidase stain 
The mean percentage of SA-β -gal-positive NP chondro-
cytes was 41.82% (range: 15.65~60.80%; SD: ±11.20%)
(Fig. 1). 
2. Telomere length 
The mean telomere length was 14.42 kb (range: 6.60~
29.80 kb; SD: ±5.73 kb) (Fig. 2).
3. Telomerase activity
The mean telomerase activity was 6.41 AUs (range:
0.8~22.3 arbitrary units; SD: ±5.37 arbitrary units).
4. H2O2 content in the NP specimens
The H2O2 content in the NP specimens was 0.25 μ mol
(range: 0.05~0.65 μ mol; SD: ±0.14 μ mol). 
5. Immunohistochemistry
Immunohistochemistry showed that the senescent NP
chondrocytes in all 25 specimens expressed p53, p21, and
pRB, but only a few NP chondrocytes in two specimens
expressed p16 (Fig. 3).
6. Statistical analysis
Among the variables (age, percentage of SA-β -gal-posi-
tive NP chondrocytes, telomere length, telomerase activity,
and H2O2 content), age and the percentage of SA-β -gal-pos-
itive NP chondrocytes showed a normal distribution. The
percentages of SA-β -gal-positive NP chondrocytes
increased with age (r=0.82, p<0.001), while the telomere
length and telomerase activity declined (r=-0.41, p=0.045
and r=-0.52, p=0.008, respectively) (Fig. 4). However, there
was no significant correlation between age and the H2O2
content (p=0.18). The NP specimens with grade III (mean±
SD: 44.11±9.40%) or IV (mean±SD: 46.02±6.11%)
degeneration showed significantly higher percentages of
SA-β -gal-positive NP chondrocytes than those with grade II
(mean±SD: 21.83±6.01%) degeneration (p=0.01 and
p=0.025, respectively).
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Fig. 1. SA-β -gal-positive nucleus pulposus chondrocytes are
shown with arrows.
Fig. 2. The telomere length (TL) of the nucleus pulposus chon-
drocytes as measured by Southern blotting.Kim et al. Senescence of Nucleus Pulposus Chondrocytes / 5
Fig. 3. Expression of p53, p21, pRB, and p16 by nucleus pulposus chondrocytes (arrows).
Fig. 4. Correlation analysis of patient age versus the percent-
age of SA-β -gal-positive nucleus pulposus chondrocytes
(Pearson’s test), telomere length (Spearman’s test), and telom-
erase activity (Spearman’s test).Discussion
In general, senescent cells become unresponsive to mito-
genic stimuli, yet they can remain viable for extended peri-
ods of time
21. They also express elevated levels of extracel-
lular matrix (ECM)-degrading proteases, collagenases, and
matrix metalloproteinase (MMP) family members
20,21. In
contrast, they express decreased levels of the MMP
inhibitor TIMP1 and decreased levels of ECM components,
such as elastin, laminin, and several forms of collagen
20,21.
These alterations indicate a general shift in the phenotype of
the senescent cells from matrix-synthesizing to matrix-
degrading
20,21,27 .
Such a shift has also been identified in aging and degen-
erated IVDs
28. The present study showed that the percent-
ages of SA-β -gal-positive NP chondrocytes increases with
age. This implies that for NP chondrocytes, like primary
cells in other organs of the body, senescence with age is
unavoidable
22. In addition, the NP specimens with grade III
or IV degeneration showed significantly higher percentages
of SA-β -gal-positive NP chondrocytes than those with
grade II degeneration, which supports the previous finding
that the senescent disc cell population increases or accumu-
lates with advancing disc degeneration
24,25. Thus, the
increase or accumulation of senescent NP chondrocytes
with aging may, at least in part, contribute to IVD degenera-
tion, whether it is natural or pathologic.  
We further showed that the telomere length and telom-
erase activity of NP chondrocytes decline with age, while
the H2O2 content has no significant correlation with age. In
articular cartilage, the chondrocytes were shown to senesce
with age via telomere shortening, which was effectively
prevented by ectopic telomerase expression
29. In contrast,
oxidative stress induced by hyperbaric culture conditions
caused premature chondrocyte senescence, which was not
effectively prevented by ectopic telomerase expression
30.
Because NP chondrocytes originate from the hyaline carti-
lage endplate
31,32, which is naturally similar to articular carti-
lage, our results imply that the senescence of NP chondro-
cytes can be caused by age-dependent telomere shortening
and/or age-independent oxidative stress, as occurs in articu-
lar chondrocytes. This may explain the increased risk of
disc degeneration with age
23 and the occurrence of unex-
pected premature or accelerated disc degeneration in some
situations, such as vertebral body fractures
33,34. 
Although SA-β -gal is a useful senescence marker, its
activity is critically dependent on detection conditions. SA-
β -gal is also expressed in non-senescent cells that have a
high lysosomal content
35,36. Multiple markers of senescence
are therefore recommended to demonstrate senescence in
vivo. For this, we further determined the expressions of p53,
p21, pRB, and p16 by immunohistochemistry. Immunohis-
tochemistry showed that the senescent NP chondrocytes in
all the specimens expressed p53, p21, and pRB, but only a
few NP chondrocytes in two specimens expressed p16.
These results indicate that the telomere-based p53, p21,
pRB pathway, rather than the stress-based p16, pRB path-
way, plays a more important role in the senescence of NP
chondrocytes. However, the co-expression of p16, although
uncommon, implies that there is a situation in which both
pathways are activated simultaneously. Thus, our results
suggest that NP chondrocytes in in vivo conditions are sub-
ject to a number of physiological stresses that act simultane-
ously, and the total stress magnitude may determine the
appropriate senescence response
1.
The results of our study, which addressed disc herniation,
may not be applicable to other degenerative disc diseases.
In addition, the NP chondrocytes in the herniated NP frag-
ments may senesce via different signaling pathways, or they
may undergo apoptosis rather than senescence
37,38. To mini-
mize any potential bias related to disc herniation, we consis-
tently obtained NP specimens from the central part of the
disc after thorough removal of the protruded or extruded
disc fragments. Further studies are required to understand
the senescence mechanisms of IVD cells in other degenera-
tive disc diseases. 
Although cellular senescence helps an organism by sup-
pressing life-threatening tumorogenesis
16,17, it can also be
detrimental to the organism by depleting renewable tissues
that contain proliferation-competent progenitor or stem
cells. In turn, such depletion can compromise the structure
and function of tissues, which is a hallmark of aging. Fur-
thermore, senescent cells can persist and acquire altered
functions, and so this alters the tissue microenvironments in
ways that can promote aging phenotypes
20,27,39. The direct
relationship between cellular senescence and IVD aging or
degeneration is unclear. However, two recent studies
24,25, in
addition to ours, have provided evidence for the potential
role of senescence of disc cells or NP chondrocytes in aging
or degenerating IVDs.     
In conclusion, the present in vivo study demonstrates that,
with increasing age and advancing disc degeneration, senes-
cent NP chondrocytes increase or accumulate in the NP.
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senescent features, such as increased SA-β -gal expression,
shortened telomeres, and decreased telomerase activity.
Further, we showed that the telomere-based p53, p21, pRB
pathway, rather than the stress-based p16, pRB pathway,
plays a more important role in the senescence of NP chon-
drocytes in in vivo conditions, although there is probably a
scenario in which both pathways are activated simultane-
ously. Because the p53, p21, pRB pathway is reversible,
prevention or reversal of NP chondrocyte senescence could
be a novel mechanism for treating human disc degeneration. 
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